Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-050638
Filing Date
2005-03-15
Accepted
2005-03-15 12:50:14
Documents
8
Period of Report
2005-01-02

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED JANUARY 2, 2005 d10k.htm 10-K 846300
2 EXECUTIVE COMPENSATION DISCLOSURE SCHEDULE dex1033.htm EX-10.33 16968
3 LIST OF SUBSIDIARIES dex21.htm EX-21 3636
4 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex23.htm EX-23 1976
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9600
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9601
7 SECTION 906 CEO & CFO CERTIFICATION dex32.htm EX-32 5139
8 IMPORTANT FACTORS REGARDING FORWARD LOOKING STATEMENTS dex99.htm EX-99 80126
  Complete submission text file 0001193125-05-050638.txt   975811
Mailing Address 175 CROSSING BLVD FRAMINGHAM MA 01701
Business Address 175 CROSSING BLVD FRAMINGHAM MA 01701 508620-970
GTC BIOTHERAPEUTICS INC (Filer) CIK: 0000904973 (see all company filings)

EIN.: 043186494 | State of Incorp.: MA | Fiscal Year End: 0103
Type: 10-K | Act: 34 | File No.: 000-21794 | Film No.: 05680872
SIC: 2836 Biological Products, (No Diagnostic Substances)